Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center.
Tögel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, Moskalev EA, Stöhr R, Agaimy A, Reis A, Wullich B, Mackensen A, Pavel M, Beckmann MW, Hartmann A, Fietkau R, Meidenbauer N, Haller F, Spoerl S. Tögel L, et al. Among authors: meidenbauer n. Cancers (Basel). 2023 Dec 18;15(24):5892. doi: 10.3390/cancers15245892. Cancers (Basel). 2023. PMID: 38136436 Free PMC article.
Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control.
Willner A, Agaimy A, Fechner K, Ott O, Denz A, Weissmann T, Meidenbauer N, Höfler D, Gaipl U, Frey B, Schmidt M, Haller F, Horch R, Hartmann A, Grützmann R, Fietkau R, Semrau S. Willner A, et al. Among authors: meidenbauer n. Int J Hyperthermia. 2023;40(1):2248424. doi: 10.1080/02656736.2023.2248424. Int J Hyperthermia. 2023. PMID: 37611915 Free article.
Extra-abdominal and intra-abdominal FET::CREM fusion mesenchymal neoplasms: comparative clinicopathological study of 9 new cases further supporting a distinct potentially aggressive sarcoma and report of novel sites.
Agaimy A, Blakely M, Breimer GE, Hölsken A, Koppes SA, Meidenbauer N, Rijken JA, Schad A, Simon AG, Stoehr R, Bishop JA, Din NU. Agaimy A, et al. Among authors: meidenbauer n. Virchows Arch. 2024 Dec;485(6):1007-1019. doi: 10.1007/s00428-024-03917-2. Epub 2024 Sep 9. Virchows Arch. 2024. PMID: 39249507 Free PMC article.
Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma - A retrospective multicenter study of the Bavarian university hospitals.
Burkhard-Meier A, Grube M, Jurinovic V, Agaimy A, Albertsmeier M, Berclaz LM, Di Gioia D, Dürr HR, von Eisenhart-Rothe R, Eze C, Fechner K, Fey E, Güler SE, Hecker JS, Hendricks A, Keil F, Klein A, Knebel C, Kovács JR, Kunz WG, Lenze U, Lörsch AM, Lutz M, Meidenbauer N, Mogler C, Schmidt-Hegemann NS, Semrau S, Sienel W, Trepel M, Waldschmidt J, Wiegering A, Lindner LH. Burkhard-Meier A, et al. Among authors: meidenbauer n. Eur J Surg Oncol. 2024 Dec;50(12):108619. doi: 10.1016/j.ejso.2024.108619. Epub 2024 Aug 23. Eur J Surg Oncol. 2024. PMID: 39270516 Free article.
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany.
Krebs M, Haller F, Spörl S, Gerhard-Hartmann E, Utpatel K, Maurus K, Kunzmann V, Chatterjee M, Venkataramani V, Maatouk I, Bittrich M, Einwag T, Meidenbauer N, Tögel L, Hirsch D, Dietmaier W, Keil F, Scheiter A, Immel A, Heudobler D, Einhell S, Kaiser U, Sedlmeier AM, Maurer J, Schenkirsch G, Jordan F, Schmutz M, Dintner S, Rosenwald A, Hartmann A, Evert M, Märkl B, Bargou R, Mackensen A, Beckmann MW, Pukrop T, Herr W, Einsele H, Trepel M, Goebeler ME, Claus R, Kerscher A, Lüke F. Krebs M, et al. Among authors: meidenbauer n. Eur J Cancer. 2024 Aug;207:114144. doi: 10.1016/j.ejca.2024.114144. Epub 2024 May 31. Eur J Cancer. 2024. PMID: 38852290 Free article.
Machine Learning-Supported Diagnosis of Small Blue Round Cell Sarcomas Using Targeted RNA Sequencing.
Schlieben LD, Carta MG, Moskalev EA, Stöhr R, Metzler M, Besendörfer M, Meidenbauer N, Semrau S, Janka R, Grützmann R, Wiemann S, Hartmann A, Agaimy A, Haller F, Ferrazzi F. Schlieben LD, et al. Among authors: meidenbauer n. J Mol Diagn. 2024 May;26(5):387-398. doi: 10.1016/j.jmoldx.2024.02.002. Epub 2024 Feb 21. J Mol Diagn. 2024. PMID: 38395409 Free article.
Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA Consortium.
Lüke F, Haller F, Utpatel K, Krebs M, Meidenbauer N, Scheiter A, Spoerl S, Heudobler D, Sparrer D, Kaiser U, Keil F, Schubart C, Tögel L, Einhell S, Dietmaier W, Huss R, Dintner S, Sommer S, Jordan F, Goebeler ME, Metz M, Haake D, Scheytt M, Gerhard-Hartmann E, Maurus K, Brändlein S, Rosenwald A, Hartmann A, Märkl B, Einsele H, Mackensen A, Herr W, Kunzmann V, Bargou R, Beckmann MW, Pukrop T, Trepel M, Evert M, Claus R, Kerscher A. Lüke F, et al. Among authors: meidenbauer n. Cancers (Basel). 2022 Oct 14;14(20):5040. doi: 10.3390/cancers14205040. Cancers (Basel). 2022. PMID: 36291825 Free PMC article.
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
Zimmermann H, Koenecke C, Dreyling MH, Pott C, Dührsen U, Hahn D, Meidenbauer N, Hauser IA, Rummel MJ, Wolf D, Heuser M, Schmidt C, Schlattmann P, Ritgen M, Siebert R, Oschlies I, Anagnostopoulos I, Trappe RU. Zimmermann H, et al. Among authors: meidenbauer n. Leukemia. 2022 Oct;36(10):2468-2478. doi: 10.1038/s41375-022-01667-1. Epub 2022 Aug 16. Leukemia. 2022. PMID: 35974101 Free PMC article. Clinical Trial.
47 results